This summer’s COVID-19 wave has gotten so bad — even worse than winter peaks in some regions — the U.S. Food and Drug Administration (FDA) announced they are approving two vaccines early, but leaving one out for now. On Thursday, the agency used its emergency use authorization (EUA) to rubber stamp a group of updated mRNA vaccines produced by Moderna and Pfizer-BioNTech. They inoculate against the SARS-CoV-2 virus, specifically the KP.2 strain, which has been driving a large proportion of infections this summer.
The vaccines (Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax) are recommended for everyone six months and older. Shots will be available in days. To find a vaccination location near you, the Department of Health and Human Services says you can text your zip code to 438829, call 1-800-232-0233 or visit vaccines.gov (though the website is still being updated as of this posting.)
“Vaccination continues to be the cornerstone of COVID-19 prevention,” Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research, said in a statement. “These updated vaccines meet the agency’s rigorous, scientific standards for safety, effectiveness and manufacturing quality. Given waning immunity of the population from previous exposure to the virus and from prior vaccination, we strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants.”
Last year, the FDA signed off on updated vaccines on September 11. But many regions are experiencing a surge this summer — with wastewater data indicating “very high” virus levels in 32 states and D.C. and an additional 11 states experiencing “high” levels. As such, reports were circulating earlier this week that the FDA may speed up approval.
mRNA vaccines use a nucleic acid known as RNA to prepare the immune system from attacks by specific pathogens. Using a bespoke RNA strand with a “message” (hence the term “messenger RNA”), mRNA vaccines transmit information about potential pathogens from genetic codes in the nucleus to the cytoplasm where pathogen-fighting proteins are manufactured. In the case of the mRNA vaccines manufactured by Pfizer and Moderna to fight COVID-19, the mRNA helps a human’s cells fight the SARS-CoV-2 virus through their spike proteins. The spike proteins are the little points that emerge out of the coronavirus, like spines jutting from a sea urchin, and the SARS-CoV-2 virus uses them to infect a patient’s cells.
Other COVID vaccines that don’t use mRNA technology are in development, such as a new shot from drugmaker Novavax. Though the company filed for EUA, it does not seem to be granted yet as the company continues to work with the FDA as it completes its review. Last year, Novavax’s shot was also approved weeks after Pfizer and Moderna were given the green light.
“We expect to have authorization in time for peak vaccination season,” Novavax said in a statement. “Our 2024-2025 formula COVID-19 vaccine targets JN.1, the ‘parent strain’ of currently circulating variants and should provide acceptable coverage and cross-reactivity against JN.1 lineage viruses, including KP.2.3, KP.3, KP.3.1.1 and LB.1.1. Upon authorization, Novavax’s vaccine will be the only protein-based option available in the U.S. for use in individuals aged 12 and older to prevent COVID-19.”
Trump is busy getting ready for Day One of his presidency – but so is Truthout.
Trump has made it no secret that he is planning a demolition-style attack on both specific communities and democracy as a whole, beginning on his first day in office. With over 25 executive orders and directives queued up for January 20, he’s promised to “launch the largest deportation program in American history,” roll back anti-discrimination protections for transgender students, and implement a “drill, drill, drill” approach to ramp up oil and gas extraction.
Organizations like Truthout are also being threatened by legislation like HR 9495, the “nonprofit killer bill” that would allow the Treasury Secretary to declare any nonprofit a “terrorist-supporting organization” and strip its tax-exempt status without due process. Progressive media like Truthout that has courageously focused on reporting on Israel’s genocide in Gaza are in the bill’s crosshairs.
As journalists, we have a responsibility to look at hard realities and communicate them to you. We hope that you, like us, can use this information to prepare for what’s to come.
And if you feel uncertain about what to do in the face of a second Trump administration, we invite you to be an indispensable part of Truthout’s preparations.
In addition to covering the widespread onslaught of draconian policy, we’re shoring up our resources for what might come next for progressive media: bad-faith lawsuits from far-right ghouls, legislation that seeks to strip us of our ability to receive tax-deductible donations, and further throttling of our reach on social media platforms owned by Trump’s sycophants.
We’re preparing right now for Trump’s Day One: building a brave coalition of movement media; reaching out to the activists, academics, and thinkers we trust to shine a light on the inner workings of authoritarianism; and planning to use journalism as a tool to equip movements to protect the people, lands, and principles most vulnerable to Trump’s destruction.
We urgently need your help to prepare. As you know, our December fundraiser is our most important of the year and will determine the scale of work we’ll be able to do in 2025. We’ve set two goals: to raise $150,000 in one-time donations and to add 1,500 new monthly donors.
Today, we’re asking all of our readers to start a monthly donation or make a one-time donation – as a commitment to stand with us on day one of Trump’s presidency, and every day after that, as we produce journalism that combats authoritarianism, censorship, injustice, and misinformation. You’re an essential part of our future – please join the movement by making a tax-deductible donation today.
If you have the means to make a substantial gift, please dig deep during this critical time!
With gratitude and resolve,
Maya, Negin, Saima, and Ziggy